Saturday 7 November 2026
Export DTIL’s income statement to Excel — free account
Precision BioSciences, Inc.
DTIL Healthcare Biotechnology
Precision BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.3 million, down 50.1% from fiscal 2024.
- Revenue
- +37,272.4%
- EPS
- +85.0%
- Free cash flow
- −0.52%
- Total debt
- +0.22%
Quarter to September 2026, against a year earlier
10.75
0.88
+8.92%
Follow DTIL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(61.52%) | (69.52%) | (132.91%) | (112.69%) | |
Piotroski F-Score |
1 | 2 | — | — | |
| (31.45%) | (32.50%) | (44.91%) | (36.04%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(41.10%) | (42.69%) | (61.77%) | (48.74%) | |
Average Days of Receivables |
0.00 | 32.39 | — | — | |
Free Cash Flow per Share |
(5.18) | (2.40) | (2.02) | (1.91) | |
Free Cash Flow |
(66.48) | (59.16) | (52.32) | (52.40) | |
Capital Expenditures |
(0.63) | (0.43) | (0.42) | (0.64) | |
| Other line items | |||||
Cash ROIC |
(28.87%) | (29.62%) | (33.70%) | (33.58%) | |
Accounts Receivable Turnover |
0.00 | 21.52 | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
158.10% | 119.13% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
94.09% | 67.65% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
29.73% | 19.77% | 0.00% | 0.00% | |
Interest Coverage |
(36.67) | (28.36) | (27.55) | (28.56) | |
Operating CF/Net income |
1.44 | 1.35 | 0.98 | 1.34 | |
Depreciation/Fixed assets |
1.45 | 1.93 | 2.45 | 3.21 | |
Capex/Depreciation |
(0.31) | (0.19) | (0.18) | (0.26) | |
Revenue per Share |
2.67 | 1.83 | 0.00 | 0.00 | |
Operating CF per Share |
(5.13) | (2.38) | (2.01) | (1.89) | |
Capex per Share |
(0.05) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.02 | 0.01 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026